Risks for melanoma skin cancer

Last medical review:

Some things can affect your risk, or chance, of developing cancer. Certain behaviours, substances or conditions can increase or decrease the risk. Most cancers are the result of many risks. But sometimes cancer develops in people who don't have any risks.

Sun and indoor tanning are the main risks for melanoma skin cancer.

The number of new cases of melanoma has increased in both men and women over the past 30 years. More men than women develop it. We need more research and can't say at this time what the risk is for transgender, non-binary and gender-diverse people. The chance of developing melanoma increases with age, but it's also found in adolescents and young adults (15 to 29 years of age).

If you have a genetic condition that increases your risk for melanoma, you may need to visit your doctor more often. Talk to your doctor about your risk and if you need to have certain tests to check for melanoma.

Some of the things that increase the risk for melanoma may also cause lentigo maligna. Lentigo maligna is a very early form of skin cancer (called melanoma in situ). It is sometimes described as a precancerous condition of the skin. If lentigo maligna isn't treated, it may become melanoma that can grow into deeper layers of the skin or surrounding tissue. Find out more about precancerous conditions of the skin.

There are several things that could increase your risk for melanoma. Most of these risks can't be changed. But in some cases, there are things you can do to lower your risk.

The following can increase your risk for melanoma:

Sun and indoor tanning

Having many moles

Atypical moles

Congenital melanocytic nevi

Familial atypical multiple mole melanoma (FAMMM) syndrome

Other genetic conditions

Light-coloured skin, eyes and hair

Personal history of skin cancer

Personal history of chronic lymphocytic leukemia (CLL)

Family history of skin cancer

CDKN2A gene mutation

Weak immune system

Contact with polychlorinated biphenyls (PCBs) at work

Tall adult height

Sun and indoor tanning

Sun and indoor tanning equipment, such as tanning beds and sun lamps, are the main risks for developing melanoma.

Having a tan means that your skin has been damaged. Sun and indoor tanning can cause sunburns, premature aging, cataracts and skin cancers.

Most cases of melanoma are caused by exposure to ultraviolet radiation (UVR) from the sun. It could be from being in the sun on and off during your lifetime or being in the sun early in your life. People who've had at least one blistering sunburn as a child or teenager have a higher risk of developing melanoma later in life. The more sunburns you've had, the greater the risk of melanoma.

Learn more about how to be sun safe.

Having many moles

A mole (also called melanocytic nevus) is a bump or spot on the skin that is usually brown or pink and has a smooth and regular border. Moles are made up of a group of melanocytes. Melanocytes are cells that give skin, hair and eyes their colour. Most people have a few moles.

Most moles are harmless. But you have a higher risk of developing melanoma if you have many moles.

Atypical moles

Atypical moles (also called dysplastic nevi) look different from normal moles. They tend to be larger than 6 mm, while normal moles are usually smaller than 6 mm. Atypical moles have an uneven or irregular shape with undefined borders. A normal mole is usually round. Atypical moles often have different colours in them, which can range from pink to dark brown. They can look like melanoma, but they are not cancerous.

Having atypical moles increases your risk of developing melanoma. This risk increases with the more atypical moles you have.

Congenital melanocytic nevi

Congenital melanocytic nevi are birthmarks or moles that are present at birth or develop shortly after. They may be classified as small (less than 1.5 cm), medium (1.5 to 19.9 cm) or large (covering more than 5% of the body in preteens or greater than 20 cm in teens or adults).

The larger the congenital melanocytic nevus, the greater the risk of developing melanoma.

Familial atypical multiple mole melanoma (FAMMM) syndrome

Familial atypical multiple mole melanoma (FAMMM) syndrome is an inherited condition in which you have many moles (usually more than 50) that often look different from normal moles. A person with FAMMM also has one or more close relatives with melanoma.

People with FAMMM syndrome have a very high risk of developing melanoma.

Other genetic conditions

A genetic condition is a disease caused by a change (mutation) in one or more genes. Having certain genetic conditions increases the risk of developing melanoma.

Xeroderma pigmentosum (XP) is an inherited condition that affects the skin so it can't repair damage caused by ultraviolet radiation from the sun. XP increases the risk of developing melanoma and non-melanoma skin cancers.

Werner syndrome is an inherited condition that causes the body to age very rapidly after puberty. Werner syndrome increases the risk for melanoma, bone, soft tissue and thyroid cancers.

Retinoblastoma is a type of eye cancer in children. Hereditary retinoblastoma is passed on from a parent to a child. It's caused by an inherited RB1 gene mutation. Children with hereditary retinoblastoma have a higher risk for melanoma later in life.

Light-coloured skin, eyes and hair

People with fair or light-coloured skin have a higher risk of developing melanoma than people with other skin types such as black or brown skin. People with blonde or red hair and blue, green or grey eyes also have a higher risk of developing melanoma. The risk is greater because people with these features have less melanin. Melanin is what gives colour to your skin, hair and eyes. It is believed that melanin also helps protect the skin from ultraviolet radiation. People with fair or light-coloured skin who had very bad sunburns at an early age have the highest risk for melanoma.

People with brown or black skin have a lower risk of developing melanoma, but they can still develop it. They may be more likely to develop a rare type of melanoma called acral lentiginous melanoma. This type of melanoma occurs on areas not exposed to the sun, such as the soles of the feet or palms of the hands.

Personal history of skin cancer

People who've already had melanoma have a higher risk of developing another primary melanoma.

Having had non-melanoma skin cancer, either basal cell carcinoma or squamous cell carcinoma, is also linked with a higher risk of developing melanoma.

Personal history of chronic lymphocytic leukemia (CLL)

If you have chronic lymphocytic leukemia (CLL), you have an increased risk of melanoma. The risk of developing melanoma is greatest within 5 years of being diagnosed with CLL. The increased risk for melanoma may be due to CLL weakening the immune system.

Family history of skin cancer

Your risk of developing melanoma increases if one or more of your first-degree relatives has been diagnosed with melanoma. This may be due to family members having similar skin colour and sun exposure habits. It can also be due to similar genetic mutations, although this is rare.

CDKN2A gene mutation

Sometimes genes can change (mutate) so they increase the risk of developing cancer. These mutated genes can be passed down from parents to their children. If several family members have the same type of cancer, or if family members have related types of cancer, they might share an inherited gene mutation.

About 5% to 25% of families with a higher risk for melanoma have an inherited mutation in the CDKN2A gene. This gene is normally a suppressor gene, which means it helps control the growth of cancer cells. When there is a CDKN2A gene mutation, cancer may develop.

Learn more about genes and cancer.

Weak immune system

Having a weak immune system (immunosuppression) increases your risk for melanoma. You may have a weak immune system for different reasons, including if you have HIV (the virus that causes AIDS) or if y ou've had an organ transplant and must take medicines to suppress your immune system.

Contact with polychlorinated biphenyls (PCBs) at work

Polychlorinated biphenyls (PCBs) are chemicals used in the plastics and chemical industries. Coming into contact with PCBs at work increases the risk for melanoma.

Learn more about how to be safe at work.

Tall adult height

Being tall as an adult has been shown to increase the risk for melanoma. It's not clear why this is. It may be that because taller people have more skin cells, there is a greater risk for mutations in the skin cells that can lead to cancer.

Possible risks

The following have been linked with melanoma, but more research is needed to know for sure that they are risks:

  • melanocortin 1 receptor (MC1R) gene mutation
  • ionizing radiation
  • greater birthweight
  • working as a firefighter
  • drinking alcohol
  • PUVA therapy

Drinking coffee has been linked with a decreased risk of melanoma, but more research is needed to know for sure that it lowers the risk.

Understanding your cancer risk

To make the decisions that are right for you, ask your doctor questions about risks. Learn how cancer can be prevented and what you can do to reduce your risk.

Expert review and references

  • Canadian Cancer Society | Société canadienne du cancer
  • Aaron DM. Moles (melanocytic nevi). Beers MH, Berkow R (eds.). Merck Manual Professional Edition. 2013. https://www.merckmanuals.com/professional.
  • American Society of Clinical Oncology (ASCO). Genetics of Melanoma. 2011.
  • Archier E, Devaux S, Castela E, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 2012.
  • Armstrong BK, Vajdic CM, Cust AE. Melanoma. Thun MJ, Linet MS, Cerhan JR, Haiman CA Schottenfeld D, eds.. Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: Kindle version, [chapter 57] https://read.amazon.ca/?asin=B0777JYQQC&language=en-CA.
  • Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto, ON: Canadian Cancer Society; 2014.
  • Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2017. Toronto, ON: Canadian Cancer Society; 2017.
  • Chang YM, Newton-Bishop JA, Bishop DT, et al. A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. International Journal of Cancer. 2009.
  • Colantonio S, Bracken MB, Beecker J. The association of indoor tanning and melanoma in adults: systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2014.
  • Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. European Journal of Cancer. Elsevier; 2005.
  • Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. European Journal of Cancer. 2005. http://www.ejcancer.com/article/S0959-8049(04)00832-9/fulltext.
  • Hale EK, Stein J, Ben-Porat L, et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi - results from the NYU-LCMN registry. British Journal of Dermatology. 2005.
  • Hollenbeak, C.S., Todd, M.M., & Billingsley, E.M., et al. Increased incidence of melanoma in renal transplantation recipients. Cancer. Hoboken, NJ: Wiley-Blackwell, Inc; 2005.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 75: Ionizing Radiation Part 1: X- and Gamma (y)-Radiation, and Neutrons. 2000.
  • International Agency for Research on Cancer (IARC). Volume 107: Polychlorinated biphenyls and polybrominated biphenyls. 2014. http://monographs.iarc.fr/ENG/Monographs/vol107/mono107.pdf.
  • International Association for Research on Cancer (IARC). IARC Monographs on the Identification of Carcinogenic Hazards to Humans Volume 132: Occupational Exposure as a Firefighter. 2023.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 100E: Personal Habits and Indoor Combustions. 2012.
  • International Agency for Research on Cancer (IARC). Volume 97: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide). 2008.
  • International Agency for Research on Cancer (IARC). Volume 55: Solar and Ultraviolet Radiation. 1992.
  • International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. International Journal of Cancer. 2007.
  • Kennedy C, Bajdik CD, Willemze R, et al. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. Journal of Investigative Dermatology. 2003.
  • Khalesi M, Whiteman DC, Tran B, Kimlin MG, Olsen CM, Neale RE. A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin. Cancer Epidemiology. 2013.
  • Krengel S, Hauschild A, Schafer T. Melanoma risk in congenital melanocytic naevi: a systematic review. British Journal of Dermatology. 2006.
  • Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. British Journal of Dermatology. 2000.
  • Loomis D, Browning SR, Schenck AP, et al. Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Occupational and Environmental Medicine. 1997.
  • Lynch HT, Shaw TG. Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity. Familial Cancer. 2016.
  • Mahon SM and Yackzan SG. Skin cancer. Yarbro CH, Wujcki D, Holmes Gobel B (eds.). Cancer Nursing: Principles and Practice. 7th ed. Sudbury, MA: Jones and Bartlett; 2011: 66:1650-1682.
  • Marrett LD, Chu MBH, Atkinson J, et al. An update to the recommended core content for sun safety messages for public education in Canada: a consensus report. Canadian Journal of Public Health. 2016.
  • Naldi L, Altieri A, Imberti GL, et al. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma: an analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes & Control. Springer Netherlands; 2005.
  • National Institutes of Health. MedlinePlus Genetics: CDKN2A Gene: Cyclin Dependent Kinase Inhibitor 2A. Bethesda, MD: US Department of Health & Human Services; 2018. https://medlineplus.gov/genetics/.
  • National Institutes of Health. MedlinePlus Genetics: MC1R Gene: Melanocortin 1 Receptor. Bethesda, MD: US Department of Health & Human Services; 2018. https://medlineplus.gov/genetics/.
  • National Institutes of Health. MedlinePlus Genetics: Retinoblastoma. Bethesda, MD: US Department of Health & Human Services; 2017. https://medlineplus.gov/genetics/.
  • National Institutes of Health. MedlinePlus Genetics: Werner Syndrome. Bethesda, MD: US Department of Health & Human Services; 2022. https://medlineplus.gov/genetics/.
  • National Institutes of Health. MedlinePlus Genetics: Xeroderma Pigmentosum. Bethesda, MD: US Department of Health & Human Services; 2023. https://medlineplus.gov/genetics/.
  • National Toxicology Program. Report on Carcinogens. 15 ed. Research Triangle Park, NC: US Department of Health and Human Services, Public Health Service; 2021. https://ntp.niehs.nih.gov/whatwestudy/assessments/cancer/roc/index.html.
  • Pouplard C, Brenaut E, Horreau C, et al. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. Journal of the European Academy of Dermatology and Venereology. 2013.
  • Raimondi S, Sera F, Gandini S, et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. International Journal of Cancer. 2008.
  • World Cancer Research Fund, American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Skin Cancer. 2019. https://www.wcrf.org/research-policy/global-cancer-update-programme/.
  • Ribas A, Ariyan CE, Barker CA. Cutaneous melanoma. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, chapter 63, https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.
  • van der Leest RJ, Flohil SC, Arends LR, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology. 2015.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society